JSL
CVS icon

JT Stratford LLC’s CVS Health CVS Stock Holding History

JT Stratford LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,392
Closed -$350K – 279
2024
Q1 		$350K Sell
4,392
-34,223
-89% -$2.61M 0.07% 211
2023
Q4 		$3.05M Sell
38,615
-1,304
-3% -$92.8K 0.7% 27
2023
Q3 		$2.79M Buy
39,919
+11,619
+41% +$823K 0.72% 28
2023
Q2 		$1.96M Sell
28,300
-2,822
-9% -$201K 0.53% 45
2023
Q1 		$2.31M Buy
31,122
+7,149
+30% +$599K 0.66% 35
2022
Q4 		$2.23M Sell
23,973
-470
-2% -$45.4K 0.71% 28
2022
Q3 		$2.33M Sell
24,443
-1,435
-6% -$142K 0.83% 28
2022
Q2 		$2.4M Sell
25,878
-766
-3% -$74.8K 0.76% 33
2022
Q1 		$2.7M Sell
26,644
-2,863
-10% -$301K 0.79% 37
2021
Q4 		$3.04M Buy
29,507
+448
+2% +$41.4K 0.83% 33
2021
Q3 		$2.47M Sell
29,059
-149
-0.5% -$12.5K 0.76% 35
2021
Q2 		$2.44M Sell
29,208
-194
-0.7% -$15.9K 0.78% 32
2021
Q1 		$2.21M Buy
29,402
+1,391
+5% +$101K 0.78% 32
2020
Q4 		$1.91M Buy
28,011
+3,099
+12% +$202K 0.72% 34
2020
Q3 		$1.46M Sell
24,912
-2,471
-9% -$154K 0.63% 44
2020
Q2 		$1.78M Sell
27,383
-6,344
-19% -$399K 0.92% 33
2020
Q1 		$2M Buy
33,727
+73
+0.2% +$4.87K 1.23% 18
2019
Q4 		$2.5M Buy
33,654
+447
+1% +$31.4K 1.15% 21
2019
Q3 		$2.09M Buy
33,207
+20,946
+171% +$1.24M 1.18% 27
2019
Q2 		$668K Buy
+12,261
New +$660K 0.37% 68

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JT Stratford LLC's CVS Position: Q2 2024 in Review

JT Stratford LLC sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,392 shares — an estimated $350K sold.

JT Stratford LLC first reported a position in CVS in Q2 2019 and held it in 20 quarters. The position peaked at $3.05M in Q4 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • JT Stratford LLC reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • JT Stratford LLC sold 4,392 CVS Health shares in Q2 2024, an estimated $350K.
  • JT Stratford LLC first reported a position in CVS Health in Q2 2019 and held it in 20 quarters.
  • JT Stratford LLC's CVS Health position peaked at $3.05M in Q4 2023.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on JT Stratford LLC's 13F filing for Q2 2024, filed 14 Aug 2024.